{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:52:38Z","timestamp":1767174758316,"version":"build-2238731810"},"reference-count":0,"publisher":"Frontline Medical Communications, Inc.","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,1]]},"DOI":"10.12788\/cutis.0554","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T13:42:47Z","timestamp":1658238167000},"source":"Crossref","is-referenced-by-count":0,"title":["Tumor Necrosis Factor \u03b1 Inhibitor\u2013Induced Lupuslike Syndrome in a Patient Prescribed Certolizumab Pegol"],"prefix":"10.12788","volume":"109","author":[{"given":"David Walton","family":"Crasto Jr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5043","published-online":{"date-parts":[[2022,6,1]]},"container-title":["Cutis"],"original-title":[],"link":[{"URL":"https:\/\/cdn.mdedge.com\/files\/s3fs-public\/CT109006018_e.PDF","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T16:01:30Z","timestamp":1667318490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdedge.com\/dermatology\/article\/255803\/dermatopathology\/tumor-necrosis-factor-inhibitor-induced-lupuslike"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":0,"aliases":["10.12788\/8\/cutis.0554"],"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,1]]},"published-print":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.12788\/cutis.0554","relation":{},"subject":[],"published":{"date-parts":[[2022,6,1]]}}}